What Unima does

Unima is a Mexican healthtech and biotechnology research company founded in 2016, headquartered in Zapopan with operations in Mexico City. The company builds and operates a low-cost diagnostic platform designed to deliver rapid disease testing to rural and underserved populations across Latin America, a segment where conventional diagnostic providers find unit economics unattractive. Through this platform, Unima has served over 500,000 patients, focusing on treatment, prevention, and diagnosis applications where traditional healthcare infrastructure is limited.

The company leverages early-stage backing from a notable set of global and regional investors, including Y Combinator (two rounds, in 2016 and 2019), Google Launchpad Accelerator, Social Capital, and multiple LatAm-focused funds such as Avalancha Ventures, Dadneo, Fondo Vulcano, and Genesis Capital Ventures. Total disclosed equity funding is approximately $3.6 million across at least two priced rounds. The leadership team consists of the founding Nuno brothers (Alejandro as Chief Scientific Officer and Jose Luis as co-founder) and operations leaders Rodrigo Nuño (Chief Manufacturing Officer) and Laura Mendoza (Chief Operating Officer), implying a vertically integrated model spanning R&D, manufacturing, and operations.

Unima's revenue model is described as recurring diagnostic services sold to rural healthcare providers, with the customer type flagged as government, suggesting public-sector health program contracts as the primary commercial channel. Pricing is characterized as "low-cost" but not publicly disclosed, and the company employs a sales-led go-to-market motion targeting underserved geographies. While Unima is recognized among notable Latin American healthtech startups alongside Mevo, 1DOC3, Pura Mente, and TRAINFES, the company remains privately held at 11–50 employees with no disclosed revenue, placing it in an early-to-growth stage within a $35 billion regional digital health market growing at 37.6% annually.

Name

Unima

Legal name

Unima

Website

https://unimadx.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Unima is a Mexican healthtech startup founded in 2016 that operates a low-cost, rapid diagnostic platform serving rural and underserved communities across Latin America, having reached over 500,000 patients through provider and government health channels.

Ownership category

akta.pro rank

Product category

Diagnostic Healthcare Services

NAICS

Diagnostic Imaging Centers (621512), Scientific Research and Development Services (5417)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)

akta.pro primary industry

Single-Cell & Spatial Omics Services (HLAGANAC)

akta.pro secondary industry

Data Integration, Interoperability & Reporting (ELR/HIE/CDC/NNDSS) (HLAJABAN)

Keywords

• Rapid disease diagnostics
• Low-cost diagnostic platform
• Rural healthcare testing
• Biotech diagnostic solutions
• Point-of-care diagnostics

Headquarters

HQ city

Zapopan

HQ country

Mexico

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Diagnostic Services: Unima generates revenue through providing low-cost diagnostic services to healthcare providers and patients in rural areas of Mexico, serving over 500,000 patients.

Go-to-market motion1 record

Core offering

Unima is a biotechnology research firm that develops and operates a low-cost diagnostic platform for rapid disease testing, targeting rural and underserved healthcare providers across Latin America. The platform enables early disease detection and treatment in communities where traditional diagnostic infrastructure is limited or prohibitively expensive. The company has served over 500,000 patients through its subscription-based diagnostic service model.

Product overview

Unima is a Mexican healthtech startup that provides a low-cost diagnostic platform serving rural areas in Latin America. The company has served over 500,000 patients with its diagnostic services, focusing on treatment, prevention, and diagnosis applications in healthcare.

Differentiator

Problem solved

Functional benefit

Products and services

• Low-cost rapid diagnostic platform

Quantifiable outcome

• Served over 500,000 patients in rural areas with low-cost diagnostics

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• 1DOC3: Colombian digital health platform offering affordable telehealth and diagnostic services to underserved populations in Latin America. Directly comparable to Unima as a fellow top-tier Latin American healthtech addressing similar access and affordability challenges.
• Mevo: Brazilian healthtech providing digital pharmacy and diagnostic solutions. Comparable to Unima as a leading Latin American healthtech cited alongside it in regional rankings, operating in adjacent primary care and diagnostics segments.
• Pura Mente: Argentine mental health and wellness platform. Comparable to Unima as another prominent Latin American healthtech recognized in the same regional cohort, addressing healthcare access through digital solutions.
• TRAINFES: Chilean healthtech offering digital rehabilitation and remote therapy solutions. Comparable to Unima as a fellow top Latin American healthtech cited in the same regional rankings, focused on accessible healthcare delivery.
• Cue Health: US-based rapid molecular diagnostic testing company offering portable testing platforms. Comparable to Unima through its focus on rapid, accessible diagnostic testing outside traditional lab settings, with potential applicability to similar low-resource environments.
• Everlywell: US-based at-home diagnostic testing platform. Comparable to Unima through its consumer-focused diagnostic testing model that prioritizes accessibility and affordability outside traditional healthcare delivery channels.

Emerging players

• Ada Health: Global symptom assessment and care navigation platform. Comparable to Unima through its focus on democratizing early disease detection and clinical decision support, though differentiated by its AI-driven symptom triage versus physical diagnostic testing.

Broad incumbents

• Doctolib: European healthcare booking and telehealth platform serving millions of patients. Comparable to Unima as a broad digital health incumbent addressing healthcare access, though at significantly larger scale and with broader geographic reach.
• Practo: India-based digital health platform combining telemedicine, diagnostics, and pharmacy delivery. Comparable to Unima through its mission to expand affordable healthcare access to underserved populations in emerging markets.
• Quest Diagnostics: Large US-based clinical laboratory services company offering comprehensive diagnostic testing. Comparable to Unima through its core focus on diagnostic testing services, though operating at significantly larger scale and in developed markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/unimadx

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds7 records

Investors13 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Unima